CY1117599T1 - Σουλφοναμιδια για την προληψη του διαβητη - Google Patents

Σουλφοναμιδια για την προληψη του διαβητη

Info

Publication number
CY1117599T1
CY1117599T1 CY20161100375T CY161100375T CY1117599T1 CY 1117599 T1 CY1117599 T1 CY 1117599T1 CY 20161100375 T CY20161100375 T CY 20161100375T CY 161100375 T CY161100375 T CY 161100375T CY 1117599 T1 CY1117599 T1 CY 1117599T1
Authority
CY
Cyprus
Prior art keywords
diabetes
sulfonamides
prevention
medicines
manufacture
Prior art date
Application number
CY20161100375T
Other languages
English (en)
Inventor
Lorenzo Piemonti
Luisa Daffonchio
Marcello Allegretti
Original Assignee
Dompé Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompé Farmaceutici S.P.A. filed Critical Dompé Farmaceutici S.P.A.
Publication of CY1117599T1 publication Critical patent/CY1117599T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51Y being a hydrogen or a carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Στο κείμενο αποκαλύπτεται η χρήση σουλφοναμιδίων του τύπου (I) όπου οι R και R1 είναι όπως ορίζονται στην περιγραφή, για την παρασκευή φαρμάκων για την πρόληψη του διαβήτη, ιδίως διαβήτη τύπου 1.
CY20161100375T 2009-10-06 2016-05-06 Σουλφοναμιδια για την προληψη του διαβητη CY1117599T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09172365A EP2308485A1 (en) 2009-10-06 2009-10-06 Sulfonamides for the prevention of diabetes
EP10768898.8A EP2485724B1 (en) 2009-10-06 2010-10-06 Sulfonamides for the prevention of diabetes

Publications (1)

Publication Number Publication Date
CY1117599T1 true CY1117599T1 (el) 2017-04-26

Family

ID=41716341

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100375T CY1117599T1 (el) 2009-10-06 2016-05-06 Σουλφοναμιδια για την προληψη του διαβητη

Country Status (25)

Country Link
US (2) US8846755B2 (el)
EP (2) EP2308485A1 (el)
JP (1) JP5745526B2 (el)
KR (1) KR101737656B1 (el)
CN (1) CN102639128B (el)
AU (1) AU2010305384B2 (el)
BR (1) BR112012007989B1 (el)
CA (1) CA2776021C (el)
CY (1) CY1117599T1 (el)
DK (1) DK2485724T3 (el)
EA (1) EA021788B1 (el)
ES (1) ES2570463T3 (el)
HK (1) HK1174557A1 (el)
HR (1) HRP20160399T1 (el)
HU (1) HUE028132T2 (el)
IL (1) IL219038A (el)
ME (1) ME02385B (el)
MX (1) MX2012004087A (el)
NZ (1) NZ599171A (el)
PL (1) PL2485724T3 (el)
RS (1) RS54693B1 (el)
SI (1) SI2485724T1 (el)
SM (1) SMT201600126B (el)
WO (1) WO2011042465A1 (el)
ZA (1) ZA201202462B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9844528B2 (en) * 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes
EP3281937A1 (en) * 2016-08-09 2018-02-14 Dompé farmaceutici S.p.A. Sulfonamides as gpr40- and gpr120-agonists
CN117503933A (zh) 2016-10-03 2024-02-06 儿童医疗中心公司 糖尿病肾病的预防和治疗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303249B1 (it) 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
ITMI20010206A1 (it) * 2001-02-02 2002-08-02 Dompe Spa Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz
US20040242498A1 (en) * 2003-02-27 2004-12-02 Collins Tassie L. CXCR3 antagonists
CN101912382B (zh) 2004-03-23 2012-11-21 冬姆佩股份公司 2-苯基丙酸衍生物及含有它们的药物组合物
PL1579859T3 (pl) 2004-03-25 2007-06-29 Dompe Pha R Ma Spa Res & Mfg Zastosowanie N-(2-arylo-propionylo)-sulfonamidów w celu leczenia uszkodzenia rdzenia kręgowego
CN102046199A (zh) * 2008-03-20 2011-05-04 卡罗勒斯治疗公司 使用抗mif抗体的治疗方法
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes
EP2308484A1 (en) * 2009-10-06 2011-04-13 Dompé S.p.a. Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets

Also Published As

Publication number Publication date
IL219038A0 (en) 2012-06-28
CN102639128A (zh) 2012-08-15
IL219038A (en) 2015-07-30
US9556115B2 (en) 2017-01-31
HRP20160399T1 (hr) 2016-05-20
HK1174557A1 (en) 2013-06-14
ES2570463T3 (es) 2016-05-18
US20150011639A1 (en) 2015-01-08
RS54693B1 (en) 2016-08-31
JP2013506703A (ja) 2013-02-28
EP2485724A1 (en) 2012-08-15
KR101737656B1 (ko) 2017-05-18
WO2011042465A1 (en) 2011-04-14
SI2485724T1 (sl) 2018-12-31
AU2010305384B2 (en) 2016-02-04
CN102639128B (zh) 2014-02-26
KR20120083889A (ko) 2012-07-26
US8846755B2 (en) 2014-09-30
NZ599171A (en) 2014-03-28
CA2776021A1 (en) 2011-04-14
BR112012007989B1 (pt) 2019-10-22
EP2308485A1 (en) 2011-04-13
EP2485724B1 (en) 2016-02-10
ZA201202462B (en) 2013-06-26
CA2776021C (en) 2017-08-01
DK2485724T3 (en) 2016-05-02
EA201270512A1 (ru) 2012-11-30
SMT201600126B (it) 2016-07-01
ME02385B (me) 2016-09-20
PL2485724T3 (pl) 2016-07-29
MX2012004087A (es) 2012-08-23
HUE028132T2 (en) 2016-11-28
JP5745526B2 (ja) 2015-07-08
AU2010305384A1 (en) 2012-04-26
EA021788B1 (ru) 2015-08-31
US20130059908A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
NL301192I2 (nl) Finerenon en zijn zouten, solvaten en solvaten van de zouten daarvan
PH12017501298A1 (en) Pesticidal compositions and processes related thereto
CY1118129T1 (el) 5-αλκυνυλ-πυριμιδινες
BR112015014562A2 (pt) composições pesticidas e processos com estas relacionados
CY1119953T1 (el) Yποκατεστημενες πυριδοπυραζινες ως προτυποι syk ανοστολεις
BRPI0816970A2 (pt) 1,3-dissubstituídas-4-fenil-1h-piridin-2-onas
DE602008005634D1 (de) 1,1,1-trifluor-2-hydroxy-3-phenylpropan-derivate
PH12015501394A1 (en) Pesticidal compositions and processes related thereto
NO20083694L (no) Bruk av rylener som markorer for vaesker
IL204621A0 (en) Bicyclic - ?? - amino acid derivatives, compositions comprising the same and uses thereof
CY1114793T1 (el) Παραγωγα αμινοπυραζολιου
BR112015013078A2 (pt) composição compreendendo uma resina de silicone e uma goma de silicone, produtos para cuidados pessoais contendo a mesma
CY1117599T1 (el) Σουλφοναμιδια για την προληψη του διαβητη
TW200700358A (en) Organic compounds
EP2578587A4 (en) PYRAZOLE DERIVATIVES
UA106880C2 (uk) Нові гербіциди
CR11057A (es) Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos
CL2008000629A1 (es) Compuestos macrociclicos derivados de 6-aril-4-mercapto-[1.3.5]triazina/[1.3]pirimidin-2-amina; composicion farmaceutica, utiles en el tratamiento del cancer.
ATE518848T1 (de) 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazinderivate
CO6251376A2 (es) Triazolilpiridina cetonas herbicidas
AP2011005697A0 (en) The 1-butyl-2-hydroxyaralkyl piperazine derivatives and the uses as anti-depression medicine thereof.
CR11449A (es) Productos intermedios gsm
DE502008002979D1 (de) Arylsulfonamide mit analgetischer wirkung
CY1114113T1 (el) Συνδυασμος ενος αναστολεα του κολπικου ρευματος if και ενος βητα-αναστολεα
RU2008136668A (ru) Пептиды, обладающие нейротропной активностью